Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos.

Mossman BT, Lippmann M, Hesterberg TW, Kelsey KT, Barchowsky A, Bonner JC.

J Toxicol Environ Health B Crit Rev. 2011;14(1-4):76-121. doi: 10.1080/10937404.2011.556047. Review.

2.

Morphological and chemical mechanisms of elongated mineral particle toxicities.

Aust AE, Cook PM, Dodson RF.

J Toxicol Environ Health B Crit Rev. 2011;14(1-4):40-75. doi: 10.1080/10937404.2011.556046. Review.

3.

Applying definitions of "asbestos" to environmental and "low-dose" exposure levels and health effects, particularly malignant mesothelioma.

Case BW, Abraham JL, Meeker G, Pooley FD, Pinkerton KE.

J Toxicol Environ Health B Crit Rev. 2011;14(1-4):3-39. doi: 10.1080/10937404.2011.556045. Review.

4.

Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases.

Huang SX, Jaurand MC, Kamp DW, Whysner J, Hei TK.

J Toxicol Environ Health B Crit Rev. 2011;14(1-4):179-245. doi: 10.1080/10937404.2011.556051. Review.

5.

A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.

Berman DW, Crump KS.

Crit Rev Toxicol. 2008;38 Suppl 1:49-73. doi: 10.1080/10408440802273156.

PMID:
18686078
6.

Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part II. Results of chronic exposure.

McConnell EE, Axten C, Hesterberg TW, Chevalier J, Miiller WC, Everitt J, Oberdörster G, Chase GR, Thevenaz P, Kotin P.

Inhal Toxicol. 1999 Sep;11(9):785-835.

PMID:
10477659
7.

Non-neoplastic and neoplastic pleural endpoints following fiber exposure.

Broaddus VC, Everitt JI, Black B, Kane AB.

J Toxicol Environ Health B Crit Rev. 2011;14(1-4):153-78. doi: 10.1080/10937404.2011.556049. Review.

8.

An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.

Gamble JF, Gibbs GW.

Regul Toxicol Pharmacol. 2008 Oct;52(1 Suppl):S154-86. doi: 10.1016/j.yrtph.2007.09.020. Epub 2007 Oct 22. Review.

PMID:
18396365
9.

Toxicological and epidemiological studies on effects of airborne fibers: coherence and public [corrected] health implications.

Lippmann M.

Crit Rev Toxicol. 2014 Sep;44(8):643-95. doi: 10.3109/10408444.2014.928266. Review. Erratum in: Crit Rev Toxicol. 2015 Jan;45(1):92.

PMID:
25168068
10.

Asbestos exposure indices.

Lippmann M.

Environ Res. 1988 Jun;46(1):86-106. Review.

PMID:
3286241
11.

Pathogenicity of a special-purpose glass microfiber (E glass) relative to another glass microfiber and amosite asbestos.

Cullen RT, Searl A, Buchanan D, Davis JM, Miller BG, Jones AD.

Inhal Toxicol. 2000 Oct;12(10):959-77.

PMID:
10989371
12.
13.

Short, fine and WHO asbestos fibers in the lungs of quebec workers with an asbestos-related disease.

Adib G, Labrèche F, De Guire L, Dion C, Dufresne A.

Am J Ind Med. 2013 Sep;56(9):1001-14. doi: 10.1002/ajim.22180. Epub 2013 Mar 26.

PMID:
23532794
14.

Translocation pathways for inhaled asbestos fibers.

Miserocchi G, Sancini G, Mantegazza F, Chiappino G.

Environ Health. 2008 Jan 24;7:4. doi: 10.1186/1476-069X-7-4. Review.

15.

Molecular basis of asbestos-induced lung disease.

Liu G, Cheresh P, Kamp DW.

Annu Rev Pathol. 2013 Jan 24;8:161-87. doi: 10.1146/annurev-pathol-020712-163942. Review.

16.
17.
18.

Asbestos, asbestosis, and lung cancer: observations in Quebec chrysotile workers.

Case BW, Dufresne A.

Environ Health Perspect. 1997 Sep;105 Suppl 5:1113-9.

19.

Risk assessment due to environmental exposures to fibrous particulates associated with taconite ore.

Wilson R, McConnell EE, Ross M, Axten CW, Nolan RP.

Regul Toxicol Pharmacol. 2008 Oct;52(1 Suppl):S232-45. doi: 10.1016/j.yrtph.2007.11.005. Epub 2007 Nov 28.

PMID:
18207296
20.

The importance of fiber biopersistence and lung dose in determining the chronic inhalation effects of X607, RCF1, and chrysotile asbestos in rats.

Hesterberg TW, Hart GA, Chevalier J, Miiller WC, Hamilton RD, Bauer J, Thevenaz P.

Toxicol Appl Pharmacol. 1998 Nov;153(1):68-82.

PMID:
9875301

Supplemental Content

Support Center